The planned area is 2 square kilometers with a total investment of 260 million US dollars. Huainan Economic and Technological Development Zone completed an investment of 654.38+billion yuan, including foreign investment of 654.38+0.654.38+0 billion US dollars.
Leading enterprises:
Anhui Xinhao Textile Co., Ltd., Anhui Dongxin Fabric Co., Ltd., Anhui Shuang Sheng Clothing Co., Ltd., Anhui Paul Printing and Dyeing Co., Ltd., Anhui Shizhen Rubber Industry Co., Ltd., Anhui Zhaoren Machinery Co., Ltd.
Leading industries: cotton spinning, linen spinning, wool spinning, textile, printing and dyeing, chemical fiber, clothing, textile machinery, electronics, fine chemicals and machinery manufacturing. 1June, 1999, Anhui Huainan Biomedical Industrial Park was established with the approval of the provincial government. The park has a planned total area of 2 square kilometers and a total investment of 654.38+0.5 billion yuan. The planned area of the first phase is 1 km2, with a total investment of 800 million yuan. It is the first biomedical industrial base in Anhui Province, the first batch of high-tech industrialization demonstration projects in Anhui Province, and the key project of "86 1" action plan in Anhui Province. At present, an investment of 800 million yuan has been completed.
There are currently 5 key enterprises in the park: the park is mainly invested by large listed companies such as Korea, Germany, Hong Kong, Jiangxi "Jiang Zhong", Anhui "Fengyuan" and Shaanxi "Dongsheng", including 7 high-tech enterprises, with more than 300 existing product varieties, which are sold to 16 countries and regions. The leading industries are biological products, biochemical pharmaceuticals and chemistry. There are more than 20 varieties of second-and third-class new drugs with independent intellectual property rights and listed in the national protection of traditional Chinese medicine.
The annual output of various synthetic APIs is 20,000 tons, ranking first in East China and first in the whole province. Among them, the output of paracetamol accounts for1/3 of the whole country;
The annual processing capacity of plasma 150 tons, ranking first in China;
Annual output of 80,000 biological products;
The annual output of cephalosporin antibiotics is 150 tons;
The annual output is 65.438+0.2 billion tablets and 6 billion capsules; Among them, the sales of compound apocynum tablets accounted for 50% of the country;
The annual output of syrup and oral liquid is 654.38+0 billion;
Annual output of pharmaceutical excipients 1500 tons, ranking third in the country and first in the province;